NASDAQ:RNAC | Operating Income | Cartesian Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$29.16M
2026-03-31-$26.5M
2025-12-31-$78.64M
2025-09-30-$21.07M
2025-06-30-$21.81M
2025-03-31-$21.89M
2024-12-31-$26.73M
2024-09-30-$17.58M
2024-06-30$13.76M
2024-03-31-$13.35M
2023-12-31-$36.33M
2023-09-30-$13.07M
2023-06-30-$18.64M
2023-03-31-$18.38M
2022-12-31-$8.5M
2022-09-30-$1.6M
2022-06-30$13.86M
2022-03-31$10.77M
2021-12-31$4.08M
2021-09-30-$1.97M
2021-06-30$452,000.00
2021-03-31-$7.16M
2020-12-31-$7.9M
2020-09-30-$13.73M
2020-06-30-$16.37M
2020-03-31-$18.82M
2019-12-31-$12.57M
2019-09-30-$11.79M
2019-06-30-$16.24M
2019-03-31-$11.86M
2018-12-31-$14.5M
2018-09-30-$15.94M
2018-06-30-$18.77M
2018-03-31-$15.81M
2017-12-31-$19.28M
2017-09-30-$13.85M
2017-06-30-$15.87M
2017-03-31-$14.78M
2016-12-31-$13.86M
2016-09-30-$7.47M
2016-06-30-$6.4M
2016-03-31-$6.94M
2015-12-31-$7.11M
2015-09-30-$6.07M
2015-06-30-$6.32M

Annual Operating Income

DateOperating Income
2025-12-31-$143.41M
2024-12-31-$43.9M
2023-12-31-$86.42M
2022-12-31$14.54M
2021-12-31-$4.6M
2020-12-31-$56.82M
2019-12-31-$52.46M
2018-12-31-$65.02M
2017-12-31-$63.78M
2016-12-31-$34.67M
2015-12-31-$25.3M
2014-12-31-$15.4M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.